The role of gray and white matter segmentation in quantitative proton MR spectroscopic imaging

Assaf Tal1, Ivan I Kirov, Robert I Grossman

  • 1Department of Radiology, New York University School of Medicine, New York, 660 First Avenue, 4th Floor, New York, New York 10016, USA.

NMR in Biomedicine
|June 21, 2012
PubMed

Insights

This study developed a method using MR spectroscopic imaging (MRSI) to correct for gray matter (GM) and white matter (WM) partial volume effects in brain metabolite measurements. The new approach enhances sensitivity and specificity for detecting metabolic changes in the brain.

Area of Science:

  • Neuroimaging
  • Biophysics
  • Medical Physics

Background:

  • Proton magnetic resonance spectroscopy (¹H-MRS) is sensitive to variations in gray matter (GM) and white matter (WM) metabolite concentrations.
  • Partial volume effects from differing GM and WM metabolite concentrations can reduce the sensitivity of single-voxel ¹H-MRS to changes.
  • MR spectroscopic imaging (MRSI) with MRI segmentation offers a method for partial volume correction in ¹H-MRS.

Purpose of the Study:

  • To determine the impact of partial volume effects on metabolic quantification in the brain.
  • To develop and validate a method for correcting partial volume effects in ¹H-MRS data using MRSI.
  • To improve the sensitivity and specificity of brain metabolite measurements by accounting for GM and WM contributions.

Main Methods:

  • Segmentation of 1-mm³ resolution MRI into GM, WM, and CSF masks.
  • Co-registration of segmented masks with the MRSI grid to determine partial volumes within each spectroscopic voxel.
  • Solving an over-determined system of equations to calculate global averaged GM and WM metabolite concentrations (C(i)(GM), C(i)(WM)).

Main Results:

  • The method improved sensitivity and specificity by combining data from multiple voxels and differentiating WM versus GM changes.
  • Unaccounted partial volume effects can alter absolute quantification by 5-10% (or more for ratios).
  • Application to 18 datasets yielded specific concentrations for N-acetylaspartate, creatine, choline, and myo-inositol in GM and WM.

Conclusions:

  • The developed MRSI-based partial volume correction method enhances brain metabolite quantification without additional hardware or time.
  • Accurate partial volume correction is crucial for reliable metabolic analysis and can reduce the required sample size for statistical significance.
  • This approach offers improved specificity to WM versus GM changes, crucial for understanding neurological conditions.